Definition of a Novel Plasmid-Based Gene Transfection Protocol of Mammalian Skeletal Muscles by Means of In Vivo Electroporation.
DNA plasmid
Green Fluorescent Protein (GFP)
biphasic pulses
electroporation
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
05 Sep 2020
05 Sep 2020
Historique:
received:
17
08
2020
revised:
02
09
2020
accepted:
03
09
2020
entrez:
9
9
2020
pubmed:
10
9
2020
medline:
25
2
2021
Statut:
epublish
Résumé
We describe an original electroporation protocol for in vivo plasmid DNA transfection. The right hind limbs of C57 mice are exposed to a specifically designed train of permeabilizing electric pulses by transcutaneous application of tailored needle electrodes, immediately after the injection of pEGFP-C1 plasmid encoding GFP (Green Fluorescente Protein). The electroporated rodents show a greater GFP expression than the controls at three different time points (4, 10, and 15 days). The electroporated muscles display only mild interstitial myositis, with a significant increase in inflammatory cell infiltrates. Finally, mild gait abnormalities are registered in electroporated mice only in the first 48 h after the treatment. This protocol has proven to be highly efficient in terms of expression levels of the construct, is easy to apply since it does not require surgical exposure of the muscle and is well tolerated by the animals because it does not cause evident morphological and functional damage to the electroporated muscle.
Identifiants
pubmed: 32899477
pii: ijms21186494
doi: 10.3390/ijms21186494
pmc: PMC7555604
pii:
doi:
Substances chimiques
Green Fluorescent Proteins
147336-22-9
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : POR Campania FESR 2014 2020
ID : CUP: B63D18000560007
Références
Gene Ther. 2003 Dec;10(26):2133-8
pubmed: 14625568
Clin Cancer Res. 2005 May 1;11(9):3175-83
pubmed: 15867210
Curr Opin Mol Ther. 2004 Oct;6(5):491-8
pubmed: 15537050
BioDrugs. 2004;18(3):155-65
pubmed: 15161333
J Vis Exp. 2009 Oct 19;(32):
pubmed: 19841615
J Pharmacol Toxicol Methods. 2017 Mar - Apr;84:11-19
pubmed: 27773843
J Histochem Cytochem. 2004 Jul;52(7):885-92
pubmed: 15208355
Front Immunol. 2013 Nov 04;4:354
pubmed: 24204366
In Vivo. 2015 Mar-Apr;29(2):217-22
pubmed: 25792648
Int J Mol Sci. 2019 Jun 06;20(11):
pubmed: 31174257
Chem Biol Interact. 2019 May 25;305:112-118
pubmed: 30935902
Dermatol Ther (Heidelb). 2018 Mar;8(1):143-146
pubmed: 29368221
Gene Ther. 2006 Dec;13(23):1619-27
pubmed: 16871232
Methods Mol Biol. 2008;433:115-25
pubmed: 18679620
Gene Ther. 2000 Jul;7(14):1171-82
pubmed: 10918485
Science. 1990 Mar 23;247(4949 Pt 1):1465-8
pubmed: 1690918
Curr Opin Drug Discov Devel. 2006 Mar;9(2):163-8
pubmed: 16566286
Clin Exp Vaccine Res. 2015 Jan;4(1):1-10
pubmed: 25648133
J Cell Biochem. 2012 Nov;113(11):3446-54
pubmed: 22678819
Int J Mol Sci. 2018 Nov 15;19(11):
pubmed: 30445702
Osteoarthritis Cartilage. 2016 Nov;24(11):1837-1849
pubmed: 26995111
Vet Clin North Am Small Anim Pract. 2019 Sep;49(5):967-979
pubmed: 31176458
Am J Physiol Cell Physiol. 2011 Nov;301(5):C1239-50
pubmed: 21832248
Biosci Rep. 2017 Nov 29;37(6):
pubmed: 29054961
FASEB J. 2008 Jun;22(6):2097-107
pubmed: 18202142
Mol Ther. 2004 Sep;10(3):447-55
pubmed: 15336645
Comput Methods Programs Biomed. 2020 Apr;186:105204
pubmed: 31760303
J Cell Physiol. 2017 Mar;232(3):490-495
pubmed: 27464761
Dermatol Pract Concept. 2017 Jul 31;7(3):21-26
pubmed: 29085716
Mol Ther. 2006 Apr;13(4):795-803
pubmed: 16309967